Syros to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Syros Pharmaceuticals (SYRS) will participate in two upcoming investor conferences to discuss advancements in the treatment of hematologic malignancies. The company's management will engage in a fireside chat at the JMP Securities 2024 Life Sciences Conference on May 14 and the TD Cowen’s 5th Annual Oncology Innovation Summit on May 29. Interested parties can access webcasts and archived recordings of the events on the Syros website.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced that company management will participate in a fireside chat at two upcoming investor conferences. Details are as follows:

JMP Securities 2024 Life Sciences Conference
Date: Tuesday, May 14
Presentation Time: 11:00 a.m. ET
Location: New York Hilton Midtown, 1335 Sixth Avenue, New York, NY

TD Cowen’s 5th Annual Oncology Innovation Summit: Insights for ASCO & EHA
Date: Wednesday, May 29
Presentation Time: 1:00 p.m. ET
Location: Virtual

To access the webcasts and subsequent archived recording of each event, please visit the Investors & Media section of the Syros website at www.syros.com. An archived replay of each webcast will be available for approximately 30 days following each presentation.

About Syros Pharmaceuticals

Syros is committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies. Driven by the motivation to help patients with blood disorders that have largely eluded other targeted approaches, Syros is developing tamibarotene, an oral selective RARα agonist in frontline patients with higher-risk myelodysplastic syndrome and acute myeloid leukemia with RARA gene overexpression. For more information, visit www.syros.com and follow us on Twitter (@SyrosPharma) and LinkedIn. 

View source version on businesswire.com: https://www.businesswire.com/news/home/20240507063235/en/

Syros Contact

Karen Hunady

Director of Corporate Communications & Investor Relations

1-857-327-7321

khunady@syros.com

Investor Contact

Amanda Isacoff

Stern Investor Relations, Inc.

212-362-1200

amanda.isacoff@sternir.com

Source: Syros Pharmaceuticals

FAQ

When will Syros participate in the JMP Securities 2024 Life Sciences Conference?

Syros will participate in the JMP Securities 2024 Life Sciences Conference on Tuesday, May 14.

Where will the TD Cowen’s 5th Annual Oncology Innovation Summit be held?

The TD Cowen’s 5th Annual Oncology Innovation Summit will be a virtual event.

How can interested parties access webcasts and archived recordings of the events?

Interested parties can visit the Investors & Media section of the Syros website at www.syros.com to access the webcasts and archived recordings of the events.